Lighthouse Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Sell
2,960
-321
-10% -$69.1K 0.39% 37
2026
Q1
$714K Sell
3,281
-86
-3% -$19.1K 0.43% 35
2025
Q4
$769K Buy
3,367
+7
+0.2% +$1.59K 0.5% 30
2025
Q3
$778K Hold
3,360
0.51% 32
2025
Q2
$624K Sell
3,360
-369
-10% -$68.6K 0.48% 35
2025
Q1
$781K Sell
3,729
-211
-5% -$41K 0.67% 28
2024
Q4
$700K Buy
+3,940
New +$724K 0.57% 32

Other funds holding ABBV

Lighthouse Financial's ABBV Position: Q2 2026 in Review

Lighthouse Financial reduced its AbbVie (ABBV) stake by 9.8% in Q2 2026, selling an estimated $69.1K and leaving 2,960 shares worth $745K. The position accounts for 0.39% of the portfolio, ranked #37.

Lighthouse Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $781K in Q1 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lighthouse Financial held 2,960 shares of AbbVie worth $745K as of Q2 2026.
  • Lighthouse Financial sold 321 AbbVie shares in Q2 2026, an estimated $69.1K.
  • AbbVie made up 0.39% of Lighthouse Financial's portfolio in Q2 2026, its #37 holding.
  • Lighthouse Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Lighthouse Financial's AbbVie position peaked at $781K in Q1 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lighthouse Financial's 13F filing for Q2 2026, filed 14 Aug 2026.